Richard Gonzalez, the current CEO, has held the role since the company's founding in 2013. He will become executive chairman on July 1st.
Michael is going to the board as well.
Gonzalez stated in a press release, "The board and I have been preparing a smooth CEO transition for some time. Rob should be given the role at this time."
The value of the pharmaceutical company's stock barely moved on Tuesday.
source: reuters.com
Michael is going to the board as well.
Gonzalez stated in a press release, "The board and I have been preparing a smooth CEO transition for some time. Rob should be given the role at this time."
The value of the pharmaceutical company's stock barely moved on Tuesday.
source: reuters.com